Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beth Israel Deaconess Medical Center, Boston, U.S.
Percutaneous coronary intervention-associated bleeding risk is correlated with increased age
August 13th, 2006
Among non-ST-segment elevation acute coronary syndrome (NSTEACS) percutaneous coronary intervention (PCI) patients treated with eptifibatide, increased age was a significant correlate of bleeding events and appeared to explain the association between low creatinine clearance and bleeding. "We aimed to identify correlates of Thrombolysis In Mycocardial Infarction (TIMI) major/minor bleeding among eptifibatide-treated patients undergoing PCI. Evaluation of bleeding predictors among patients treated with glycoprotein IIb/IIIa receptor inhibition might aid in the identification of targets to reduce bleeding risk," scientists writing in the Journal of the American College...
Source: Health Insurance Law Weekly (2006-08-13)
|
